MedPath

ACCEL-BICALUTAMIDE TABLETS USP

ACCEL-BICALUTAMIDE TABLETS USP

Discontinued
DIN Number

02400731

Drug Class

Human

Market Date

N/A

Company
HC

accel pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02400731
AIG Number0127996001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BB03 BICALUTAMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BICALUTAMIDEActive
Strength: 50 MG
Monograph: BICALUTAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.